Tvardi Therapeutics
Houston
About Tvardi Therapeutics
Tvardi Therapeutics they are focused on the development of orally delivered, small molecule inhibitors of STAT3. They provide medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $81.4M
- Funding stage: M&A
- Last round: Series B (Jun 2021)
- Ticker: nasdaq:TVRD
- Website: tvarditherapeutics.com
- Phone: 832-413-1362
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Service Industry
Social Profiles
Canonical: https://fsome.com/organization/tvardi-therapeutics-33181 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.